Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

Medical Marijuana Got A Major Federal Upgrade

For the first time in more than 50 years, the federal government has fundamentally changed how it classifies medical marijuana, and for millions of patients and researchers, this is a very big deal. Effective April 28, 2026, the Justice Department and the Drug Enforcement Administration officially moved FDA-approved cannabis products and state-licensed medical marijuana from Schedule I to Schedule III of the Controlled Substances Act. Schedule I — the most restrictive category, reserved for substances with “no accepted medical use” — is where marijuana has sat since 1970, alongside heroin. Moving to Schedule III, the same category as ketamine and certain anabolic steroids, is a landmark shift that recognizes what 40 U.S. states have already acknowledged for years: medical marijuana has genuine therapeutic value. For patients, the change could improve access and affordability, as medical cannabis businesses will no longer face a punishing tax rule that had effectively prohibited them from deducting standard business expenses, often pushing effective federal tax rates on those businesses as high as 70 to 80 percent.

For scientists, the rescheduling is equally significant. Schedule I status has long created enormous barriers to cannabis research, making it exceptionally difficult to study a substance tens of millions of Americans already use. Researchers studying everything from chronic pain to epilepsy to PTSD have faced federal restrictions that simply don’t apply to other substances under study. Those barriers will now ease meaningfully. A DEA administrative hearing beginning June 29, 2026, will consider whether the rescheduling extends to all marijuana — including recreational products. For now, the immediate and historic win belongs to the patients, doctors, and researchers who have long argued that science, not stigma, should drive federal drug policy.

Source: https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3aae122b1a91f8e4b6c690268

PrevPreviousA Pill That Costs Pennies And Has Been Around For 125 Years May Also Fight Cancer

Recent Articles

Happy News

Medical Marijuana Got A Major Federal Upgrade

April 28, 2026

For the first time in more than 50 years, the federal government has fundamentally changed how it classifies medical marijuana, and for millions of patients and researchers, this is a very big deal. Effective April 28, 2026, the Justice Department and the Drug Enforcement Administration officially moved FDA-approved cannabis products

Read More
Happy News

A Pill That Costs Pennies And Has Been Around For 125 Years May Also Fight Cancer

April 28, 2026

A pill that has been sitting in medicine cabinets for more than a century is showing signs of being far more powerful than anyone originally imagined, as a growing body of clinical evidence points to aspirin as a meaningful weapon against cancer. Researchers at the Karolinska Institute in Sweden tracked

Read More
Happy News

Doctors Just Gave 133 People Their Sight Back For Free

April 28, 2026

When a nurse peeled back the bandage from 84-year-old Gladys Khoza’s eye the morning after her cataract surgery, the first word out of her mouth was one that said everything: wow. Khoza had been waiting nearly a year to have the simple 15-minute procedure that would clear her clouded lens

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.